Abstract
We determine the complete atomic-level structure of the amorphous form of the drug altuliflapon, a 5-lipooxygenase activating protein (FLAP) inhibitor, by chemical shift driven NMR crystallography. The ensemble of preferred...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
